Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'

Abbott Laboratories CEO Robert Ford unpacked his company's latest quarterly report in a Thursday interview with CNBC's Jim Cramer.

Source: CNBC

Continue reading...